Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Chromosome changes in hematologic malignancies.

R A Larson, H M Golomb, J D Rowley

CA: a Cancer Journal for Clinicians

|July 1, 1981

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Late Relapse in Hodgkin's Disease: Report of Five Cases and a Review of the Literature.

Leukemia & lymphoma·2016

Same author

Survival Experience of 195 Patients with Hairy Cell Leukemia Treated in a Multi-Institutional Study with Interferon-Alfa 2B.

Leukemia & lymphoma·2016

Same author

Familial Lymphoproliferative Disorders with Chromosomal Fragile Site Analysis.

Leukemia & lymphoma·2016

Same author

Low Dose Interferon Alfa-2B for the Induction of Remission of Hairy Cell Leukemia: A Multi-institutional Study of 49 Patients.

Leukemia & lymphoma·2016

Same author

HDS: Establishment of a New Cell Line from a Hairy Cell Leukemia Patient with Resistance to Alpha-Interferon Therapy.

Leukemia & lymphoma·2016

Same author

The Treatment of Hairy Cell Leukemia: A Review.

Leukemia & lymphoma·2016

Same journal

Serious mental illness and cancer: A call to action for equitable care.

CA: a cancer journal for clinicians·2026

Same journal

Extranodal natural killer/T-cell lymphoma: From fatal to curable.

CA: a cancer journal for clinicians·2026

Same journal

Data support longer recurrence-free survival with nivolumab than with ipilimumab for stage III or IV melanoma.

CA: a cancer journal for clinicians·2026

Same journal

Study finds ovarian cancer survivors who are BRCA carriers have a relatively low risk of breast cancer.

CA: a cancer journal for clinicians·2026

Same journal

Radiation therapy, cytogenetic prognostication, novel systemic chemotherapy, and patient perspective in an adult with choroidal melanoma.

CA: a cancer journal for clinicians·2026

Same journal

Systemic amyloid light-chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates.

CA: a cancer journal for clinicians·2026

See all related articles

Chromosome changes are key to cancer development. Advanced analysis of these changes helps identify specific cancer subtypes, improving diagnosis, prognosis, and targeted therapies for hematologic neoplasms.

Area of Science:

Oncology
Genetics
Cell Biology

Background:

Chromosome abnormalities are critical events in cellular malignant transformation.
Identifying specific subtypes of hematologic neoplasms, like t(15;17) acute promyelocytic leukemia (APL) or Philadelphia chromosome-positive chronic myeloid leukemia (CML), is crucial for diagnosis and prognosis.

Purpose of the Study:

To explore the role of chromosome changes in malignant transformation.
To investigate how sophisticated cytogenetic analysis can identify new subtypes of hematologic neoplasms.
To correlate cytogenetic findings with potential etiologic factors and biochemical abnormalities for improved disease classification and therapy.

Main Methods:

Analysis of clinical and cytogenetic parameters.
Ongoing cytogenetic studies to identify correlations between chromosome abnormalities and potential etiologic factors (e.g., occupational exposure, prior therapy, family history).

Related Experiment Videos

Integration of human gene map data to link chromosomal changes with biochemical abnormalities.

Main Results:

Accumulating evidence links chromosome changes to malignant transformation.
Sophisticated analysis enables identification of specific hematologic neoplasm subtypes with diagnostic and prognostic significance.
Potential correlations between environmental/genetic factors and specific chromosome abnormalities in leukemia and lymphoma are being investigated.

Conclusions:

Chromosome abnormalities are fundamental to cancer development.
Enhanced cytogenetic analysis improves the classification of hematologic neoplasms.
Understanding the link between chromosomal and biochemical changes will advance targeted cancer therapies.